Terms: = Leukemia AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Clinical Outcome
32 results:
1. clinical outcome of therapy-related acute myeloid leukemia patients. Real-life experience in a University Hospital and a Cancer Center in France.
Belhabri A; Heiblig M; Morisset S; Vila L; Santana C; Nicolas-Virelizier E; Hayette S; Tigaud I; Plesa A; Labussiere-Wallet H; Sobh M; Michallet AS; Marie B; Nicolini FE; Guillermin Y; Gaëlle F; Lebras L; Rey P; Jauffret-Bertholon L; Laude MC; Sandrine L; Michallet M
Cancer Med; 2023 Aug; 12(16):16929-16944. PubMed ID: 37548369
[TBL] [Abstract] [Full Text] [Related]
2. Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome.
Pastore F; Gittinger H; Raab S; Tschuri S; Ksienzyk B; Konstandin NP; Schneider S; Rothenberg-Thurley M; Horny HP; Werner M; Sauerland MC; Amler S; Görlich D; Berdel WE; Wörmann B; Braess J; Hiddemann W; Tischer J; Herold T; Metzeler KH; Spiekermann K
Br J Haematol; 2023 Sep; 202(6):1165-1177. PubMed ID: 37455345
[TBL] [Abstract] [Full Text] [Related]
3. Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid leukemia.
Eriksson A; Engvall M; Mathot L; Österroos A; Rippin M; Cavelier L; Ladenvall C; Baliakas P
Clin Cancer Res; 2023 Aug; 29(15):2826-2834. PubMed ID: 37022349
[TBL] [Abstract] [Full Text] [Related]
4. Association of genetic variants and survival in patients with acute myeloid leukemia in rural Appalachia.
Shultz C; Gates C; Petros W; Ross K; Veltri L; Craig M; Wen S; Primerano DA; Hazlehurst L; Denvir J; Sdrimas K
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1746. PubMed ID: 36382570
[TBL] [Abstract] [Full Text] [Related]
5. Integration of CD34
Li XP; Zhang WN; Mao JY; Zhao BT; Jiang L; Gao Y
J Transl Med; 2022 Aug; 20(1):359. PubMed ID: 35962395
[TBL] [Abstract] [Full Text] [Related]
6. Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia.
Cao Y; Liu Y; Shang L; Chen H; Yue Y; Dong W; Guo Y; Yang H; Yang X; Liu Y; Gu W; Zhang X
Int J Clin Oncol; 2022 Jul; 27(7):1222-1232. PubMed ID: 35536524
[TBL] [Abstract] [Full Text] [Related]
7. Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia.
Stasik S; Eckardt JN; Kramer M; Röllig C; Krämer A; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Naumann R; Steffen B; Kunzmann V; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause S; Herbst R; Hänel M; Frickhofen N; Noppeney R; Kaiser U; Baldus CD; Kaufmann M; Rácil Z; Platzbecker U; Berdel WE; Mayer J; Serve H; Müller-Tidow C; Ehninger G; Bornhäuser M; Schetelig J; Middeke JM; Thiede C;
Blood Adv; 2021 Sep; 5(17):3279-3289. PubMed ID: 34459887
[TBL] [Abstract] [Full Text] [Related]
8. Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification.
van der Werf I; Wojtuszkiewicz A; Meggendorfer M; Hutter S; Baer C; Heymans M; Valk PJM; Kern W; Haferlach C; Janssen JJWM; Ossenkoppele GJ; Cloos J; Haferlach T
Blood Adv; 2021 Sep; 5(17):3254-3265. PubMed ID: 34448812
[TBL] [Abstract] [Full Text] [Related]
9. Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement.
Bill M; Mrózek K; Giacopelli B; Kohlschmidt J; Nicolet D; Papaioannou D; Eisfeld AK; Kolitz JE; Powell BL; Carroll AJ; Stone RM; Garzon R; Byrd JC; Bloomfield CD; Oakes CC
J Hematol Oncol; 2021 Jul; 14(1):107. PubMed ID: 34229733
[TBL] [Abstract] [Full Text] [Related]
10. A higher percentage of leukemic blasts with vacuoles predicts unfavorable outcomes in patients with acute myeloid leukemia.
Song J; Shang B; Pei Y; Shi M; Niu X; Dou L; Drokow EK; Xu F; Bai Y; Sun K
Leuk Res; 2021 Oct; 109():106638. PubMed ID: 34116372
[TBL] [Abstract] [Full Text] [Related]
11. clinical outcome of older adults with acute myeloid leukemia: An analysis of a large tertiary referral Center over two decades.
Ihlow J; Gross S; Neuendorff NR; Busack L; Herneth A; Singh A; Schwarz M; Flörcken A; Anagnostopoulos I; Türkmen S; Burmeister T; Blau IW; Bullinger L; Westermann J
J Geriatr Oncol; 2021 May; 12(4):540-549. PubMed ID: 33223482
[TBL] [Abstract] [Full Text] [Related]
12. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/
Bill M; Mrózek K; Kohlschmidt J; Eisfeld AK; Walker CJ; Nicolet D; Papaioannou D; Blachly JS; Orwick S; Carroll AJ; Kolitz JE; Powell BL; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26340-26346. PubMed ID: 33020282
[TBL] [Abstract] [Full Text] [Related]
13. Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.
Rodríguez-Veiga R; Montesinos P; Boluda B; Lorenzo I; Martínez-Cuadrón D; Salavert M; Pemán J; Calvillo P; Cano I; Acuña E; Villalba A; Piñana JL; Sanz J; Solves P; Senent L; Vicente A; Sempere A; Cervera J; Barragán E; Jarque I; Torres A; Sanz MA; Sanz GF
Ann Hematol; 2019 Sep; 98(9):2081-2088. PubMed ID: 31240471
[TBL] [Abstract] [Full Text] [Related]
14. Comparative safety and efficacy of tyrosine kinase inhibitors (TKIs) in the treatment setting of different types of leukemia, and different types of adenocarcinoma.
Yazdi MH; Faramarzi MA; Nikfar S; Abdollahi M
Biomed Pharmacother; 2017 Nov; 95():1556-1564. PubMed ID: 28950655
[TBL] [Abstract] [Full Text] [Related]
15. A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients.
Beck D; Thoms JAI; Palu C; Herold T; Shah A; Olivier J; Boelen L; Huang Y; Chacon D; Brown A; Babic M; Hahn C; Perugini M; Zhou X; Huntly BJ; Schwarzer A; Klusmann JH; Berdel WE; Wörmann B; Büchner T; Hiddemann W; Bohlander SK; To LB; Scott HS; Lewis ID; D'Andrea RJ; Wong JWH; Pimanda JE
Leukemia; 2018 Feb; 32(2):263-272. PubMed ID: 28674423
[TBL] [Abstract] [Full Text] [Related]
16. NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.
Chretien AS; Fauriat C; Orlanducci F; Rey J; Borg GB; Gautherot E; Granjeaud S; Demerle C; Hamel JF; Cerwenka A; von Strandmann EP; Ifrah N; Lacombe C; Cornillet-Lefebvre P; Delaunay J; Toubert A; Arnoulet C; Vey N; Olive D
Oncotarget; 2017 Jul; 8(30):49548-49563. PubMed ID: 28548938
[TBL] [Abstract] [Full Text] [Related]
17. Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.
Gunnarsson N; Sandin F; Höglund M; Stenke L; Björkholm M; Lambe M; Olsson-Strömberg U; Richter J; Själander A
Eur J Haematol; 2016 Oct; 97(4):387-92. PubMed ID: 26833713
[TBL] [Abstract] [Full Text] [Related]
18. Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade.
Badar T; Kantarjian HM; Nogueras-Gonzalez GM; Borthakur G; Garcia Manero G; Andreeff M; Konopleva M; Kadia TM; Daver N; Wierda WG; Luthra R; Patel K; Oran B; Champlin R; Ravandi F; Cortes JE
Am J Hematol; 2015 Nov; 90(11):1065-70. PubMed ID: 26299958
[TBL] [Abstract] [Full Text] [Related]
19. Flow cytometric maturity score as a novel prognostic parameter in patients with acute myeloid leukemia.
Schneider T; Flörcken A; Singh A; Türkmen S; Burmeister T; Anagnostopoulos I; Pezzutto A; Dörken B; Westermann J
Ann Hematol; 2015 Aug; 94(8):1337-45. PubMed ID: 25994787
[TBL] [Abstract] [Full Text] [Related]
20. Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines.
Molica S; Giannarelli D; Mirabelli R; Levato L; Gentile M; Lentini M; Morabito F
Expert Rev Hematol; 2014 Oct; 7(5):691-5. PubMed ID: 25174547
[TBL] [Abstract] [Full Text] [Related]
[Next]
